Sino Biopharmaceutical Limited

SEHK:1177 Voorraadrapport

Marktkapitalisatie: HK$64.4b

Sino Biopharmaceutical Dividend

Dividend criteriumcontroles 0/6

Sino Biopharmaceutical is a dividend paying company with a current yield of 1.67%.

Belangrijke informatie

1.7%

Dividendrendement

0.9%

Terugkoop Rendement

Totaal aandeelhoudersrendement2.6%
Toekomstig dividendrendement2.6%
Dividendgroei14.1%
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeelHK$0.060
Uitbetalingsratio47%

Recente dividendupdates

Recent updates

After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar

Oct 02
After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar

Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Sep 02
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?

Jul 12
Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?

Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

May 21
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings

Apr 21
Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings

What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates

Apr 03
What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates

Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price

Mar 20
Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price

Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon

Dec 18
Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon

Does Sino Biopharmaceutical (HKG:1177) Have A Healthy Balance Sheet?

Dec 02
Does Sino Biopharmaceutical (HKG:1177) Have A Healthy Balance Sheet?

Sino Biopharmaceutical Limited (HKG:1177) Shares Could Be 41% Below Their Intrinsic Value Estimate

Nov 17
Sino Biopharmaceutical Limited (HKG:1177) Shares Could Be 41% Below Their Intrinsic Value Estimate

We Think Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt With Ease

Aug 30
We Think Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt With Ease

Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 50% Undervaluation?

May 26
Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 50% Undervaluation?

Sino Biopharmaceutical (HKG:1177) Has A Rock Solid Balance Sheet

Apr 20
Sino Biopharmaceutical (HKG:1177) Has A Rock Solid Balance Sheet

Is Sino Biopharmaceutical Limited (HKG:1177) Trading At A 38% Discount?

Feb 09
Is Sino Biopharmaceutical Limited (HKG:1177) Trading At A 38% Discount?

Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?

Nov 11
Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?

Sino Biopharmaceutical (HKG:1177) Seems To Use Debt Quite Sensibly

Oct 24
Sino Biopharmaceutical (HKG:1177) Seems To Use Debt Quite Sensibly

Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 46% Undervaluation?

Jul 08
Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 46% Undervaluation?

Is Sino Biopharmaceutical (HKG:1177) Using Too Much Debt?

Apr 28
Is Sino Biopharmaceutical (HKG:1177) Using Too Much Debt?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: 1177 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.

Groeiend dividend: 1177 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.


Dividendrendement versus markt

Sino Biopharmaceutical Dividendrendement versus markt
Hoe verhoudt 1177 dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (1177)1.7%
Markt onderkant 25% (HK)3.2%
Markt Top 25% (HK)7.9%
Gemiddelde industrie (Pharmaceuticals)3.7%
Analist prognose (1177) (tot 3 jaar)2.6%

Opmerkelijk dividend: 1177's dividend (1.67%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.25%).

Hoog dividend: 1177's dividend (1.67%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.92%).


Winstuitkering aan aandeelhouders

Verdiendekking: 1177 is not paying a notable dividend for the Hong Kong market.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: 1177 is not paying a notable dividend for the Hong Kong market.


Ontdek bedrijven met een sterk dividend